J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on February 1, 2007 Originally published In Press as doi:10.1194/jlr.R600030-JLR200 on December 6, 2006 Originally published In Press as doi:10.1194/jlr.R600030-JLR200 on December 1, 2006

Papers In Press, published online ahead of print December 5, 2006
J. Lipid Res., doi:10.1194/jlr.R600030-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
R600030-JLR200v1
R600030-JLR200v2
R600030-JLR200v3
48/2/267    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tegnér, J.
Right arrow Articles by Björkegren, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tegnér, J.
Right arrow Articles by Björkegren, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on November 14, 2006
Revised on November 28, 2006
Accepted on December 1, 2006

Multi-organ whole-genome measurements and reverse engineering to uncover gene networks underlying complex traits

Jesper Tegnér, Josefin Skogsberg, and Johan Björkegren

Medicine, Center for Molecular Medicine, Stockholm 171 76

Corresponding Author: johan.bjorkegren{at}ki.se

The development of whole-genome measurement technologies together with computational analysis and modeling hold the potential to fundamentally change research of complex disorders such as coronary artery disease. With these tools, the stage has been set to reveal the full repertoire of biological components (genes, proteins, and metabolites) in complex diseases and their interplay in modules and networks. Here we review how network identification based on reverse engineering, as applied to whole-genome datasets from simpler organisms, is now being adapted to more complex settings such as datasets from human cell lines and organs in relation to physiological and pathological states. Our focus is on the use of a systems biological approach to identify principle as well as biological gene networks in coronary atherosclerosis. We also address as to how gene networks will likely play a key role in the development of early diagnostics and treatments for complex disorders in the coming era of individualized medicine.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.